- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00000387
Self-Management Therapy for Youth With Schizophrenia (FamCent)
The purpose of this study is to test the effectiveness of a family-centered, community-based, self-management intervention (Self-Management Therapy) for adolescents with schizophrenia. The study will test the intervention's effectiveness in improving the adolescents' behavior, thinking, mood, and use of substances such as drugs and alcohol. The study also will look at the effects of the patient on the family.
The intervention involves training in recognizing symptoms of schizophrenia and in stress management, problem-solving, and social skills. Parents and siblings are included to gain knowledge and skills to support the adolescents.
The Self-Management Therapy intervention is administered in small multiple-family groups in 12 sessions over 7-1/2 months. The effects of the intervention on the patient and his/her family are assessed prior to treatment, after 6 sessions, after 12 sessions, and in a follow-up visit 6 months after completion of sessions.
A child may be eligible for this study if he/she:
Is 15 to 19 years old and has been diagnosed with schizophrenia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To test the effectiveness of a family-centered, community-based, self-management intervention (Self-Management Therapy) for adolescents with schizophrenia. The primary aim is to test its effectiveness in improving the adolescents' level of functioning in role performance, thinking/cognitive processing, behavior towards others, mood, and use of substances. The second aim is to assess the impact of the intervention on family functioning. The third aim is to describe the relationships among the process variables of the intervention.
Nakagawa-Kogan's self-management nursing model, Kanfer's self-regulation theory, and Liberman's theory of stress and vulnerability provide the theoretical basis for the self-management intervention developed specifically for a population with deficits in cognitive processing. The intervention involves training in symptom awareness, stress management skills, problem-solving, and social skills. Parents and siblings are included to gain knowledge and skills to support the adolescents.
The adolescent's level of functioning is assessed using the Child and Adolescent Functional Assessment Scale, the Birchwood Early Signs & Symptoms Scale for schizophrenia, and the DISA. Family Functioning is assessed by computing a Composite Family Functioning Index using weighted scores from the FACES II, Family Apgar, Family Empowerment, and Family Social Support scales. One parent is designated by the family to be the family respondent on the scales. The adolescents are referred to the study by mental health professionals. The intervention is administered in small multiple-family groups in 12 sessions over 7-1/2 months. Data are collected at 4 points in time: at baseline, after 6 intensive sessions, after 6 monthly reinforcement sessions, and 6 months post-intervention. ANCOVA is used to test the study hypotheses. Multivariate relationships are examined among the process variables of the intervention.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
Patients must have:
Schizophrenia as diagnosed according to DSM-IV criteria when screened by a mental health professional using the K-SADS and the DISA.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: A,1,III
Behavioral intervention - Self management therapy
|
Behavioral
|
Active Comparator: A,2,III
Regular treatment
|
Behavioral
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Increase in CAFAS level of functioning for all adolescents.
Time Frame: Over the course of 14 months
|
Over the course of 14 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Increase in family functioning for families in the treatment group according to the designated family respondent.
Time Frame: Over the course of 14 months
|
Over the course of 14 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Karen G. Schepp, PhD
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH056580 (U.S. NIH Grant/Contract)
- DSIR CT-S
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Rakitzi, StavroulaActive, not recruiting
-
Peking UniversityNot yet recruitingTreatment-resistant Schizophrenia
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
Clinical Trials on Self-management therapy
-
US Department of Veterans AffairsCompleted
-
Hamilton Health Sciences CorporationOntario Ministry of Health and Long Term CareCompletedHypertension | Obesity | Arthritis | Back Pain | Chronic DiseaseCanada
-
Yale UniversityNational Institute of Nursing Research (NINR); Milton S. Hershey Medical CenterCompletedHeart Failure | Pain | Fatigue | Sleep Initiation and Maintenance Disorders | Anxiety | Depressive Symptoms | Congestive Heart Failure | Sleep Disorders | Chronic Insomnia | Heart Failure, Congestive | Cardiac Failure | Disorders of Initiating and Maintaining SleepUnited States
-
University of MichiganNational Institute of Nursing Research (NINR)Completed
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); American Lung Association; Nemours Children's Health SystemActive, not recruitingYoung Adults | Uncontrolled AsthmaUnited States
-
Stanford UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedOsteoarthritis | Rheumatoid ArthritisUnited States, Canada
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Francis Family FoundationNot yet recruitingCritical Illness | Respiratory Failure | Anxiety
-
Radboud University Medical CenterCompleted
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedMultiple Sclerosis | Low Back Pain | Chronic Pain | Muscular Dystrophies | Spinal Cord Injury | Other and Unspecified Amputation Stump ComplicationsUnited States
-
University of Southern DenmarkZealand University Hospital; Holbaek Sygehus; Naestved Hospital; Nykøbing Falster... and other collaboratorsActive, not recruitingDepression | Heart Failure | Hypertension | Chronic Obstructive Pulmonary Disease | Osteoarthritis, Knee | Coronary Heart Disease | Osteoarthritis, Hip | Type2 DiabetesDenmark